Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACAM: Niacinamide in Cardiac Surgery Associated Myocardial Injury
NCT04750616Phase 2Completed
- Sponsor
- Kaiser Permanente
- Start
- Sep 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide in acute kidney injury (AKI), Myocardial injury, ischemia-reperfusion injury (IRI), sponsored by Kaiser Permanente. Started Sep 2021; status: completed.
02
Drugs
nicotinamide
03
Conditions
acute kidney injury (AKI)Myocardial injuryischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT04750616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750616.